Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German industry concern over DEHP motive:

This article was originally published in Clinica

Executive Summary

The German health ministry's federal pharmaceutical and medical technology research institute's (BfArM) resurrection last month of the debate on DEHP and its current uses in medical devices has been viewed with suspicion by local industry association Spectaris. International environmental groups urge caution in the use of the PVC softener in neonates and pre-pubescent males, among other recommendations. BfArM has put up for debate a proposal that the replacement of DEHP-containing products with alternatives be the subject of a legal order in Germany (see Clinica No 1143, p 6). Spectaris said in its January infoletter that the industry would reject any such move that would, in fact, see Germany taking a lone stance in this respect.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054258

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel